Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

Informations projet

SQUEEZE

N° de convention de subvention: 101095052

DOI

10.3030/101095052

Date de signature de la CE 25 Novembre 2022

Date de début 1 Decembre 2022

Date de fin 30 Novembre 2027

Financé au titre de

• Health

Coût total

€ 9 197 602,50

Contribution de l’UE

€ 9 197 602,50

Coordonné par

MEDIZINISCHE UNIVERSITAET WIEN
Austria

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Documents, reports (11)

Descriptive map of TTV values
Ethics and Governance framework

Building the framework for ethics and governance

First submission package of RA-DRUM trial
Report on Associations between serum drug levels and anti-drug antibodies and clinical outcomes
Report on Data platform, warehousing and data & script sharing
Updated Plan on dissemination, exploitation and communication (DEC) of results

This deliverable gives an overview of the planned DEC activities for the project- including planned events and activities, and a first version of communication documents and templates- and a collection of PPTs that can be used as a basis for presentation of Squeeze. The PPTs and templates collected on the Squeeze online portal (for consortium only) will be updated as needed. The report includes website implementation in a first version (including public information/PPTs) and social media (current plan is focusing on LinkedIn and Twitter) initiated.

Risk assessment Report, study monitoring will be carried out throughout the trial with end of study report

First submission package BioBest Trial

Report on SQUEEZE stakeholder strategy
Conclusions from the Kick-off Meeting

Summary reporting of Kick-off meeting

First submission package of MethMax trial; reporting of MTX responder dynamics

First submission package of MethMax trial and reporting of MTX responder dynamics to inform trial

Report with contextual analysis - Map of practice patterns of RA care, use of precision medicine approaches

Websites, patent fillings, videos etc. (1)

public web site